Glucagon-like peptide-1 receptor agonist initiation and risk of clinically recorded Alzheimer's disease-type dementia in older adults with type 2 diabetes: a target trial emulation using causal machine learning

Schroeder, J. et al.

bioRxiv / medRxiv · Papers · License: Open Access

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1043967
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.